» Articles » PMID: 12482714

Dlx5 is a Positive Regulator of Chondrocyte Differentiation During Endochondral Ossification

Overview
Journal Dev Biol
Publisher Elsevier
Date 2002 Dec 17
PMID 12482714
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The process of endochondral ossification in which the bones of the limb are formed after generation of cartilage models is dependent on a precisely regulated program of chondrocyte maturation. Here, we show that the homeobox-containing gene Dlx5 is expressed at the onset of chondrocyte maturation during the conversion of immature proliferating chondrocytes into postmitotic hypertrophying chondrocytes, a critical step in the maturation process. Moreover, retroviral misexpression of Dlx5 during differentiation of the skeletal elements of the chick limb in vivo results in the formation of severely shortened skeletal elements that contain excessive numbers of hypertrophying chondrocytes which extend into ectopic regions, including sites normally occupied by immature chondrocytes. The expansion in the extent of hypertrophic maturation detectable histologically is accompanied by expanded and upregulated domains of expression of molecular markers of chondrocyte maturation, particularly type X collagen and osteopontin, and by expansion of mineralized cartilage matrix, which is characteristic of terminal hypertrophic differentiation. Furthermore, Dlx5 misexpression markedly reduces chondrocyte proliferation concomitant with promoting hypertrophic maturation. Taken together, these results indicate that Dlx5 is a positive regulator of chondrocyte maturation and suggest that it regulates the process at least in part by promoting conversion of immature proliferating chondrocytes into hypertrophying chondrocytes. Retroviral misexpression of Dlx5 also enhances formation of periosteal bone, which is derived from the Dlx5-expressing perichondrium that surrounds the diaphyses of the cartilage models. This suggests that Dlx5 may be involved in regulating osteoblast differentiation, as well as chondrocyte maturation, during endochondral ossification.

Citing Articles

Hypertrophic chondrocytes at the junction of musculoskeletal structures.

Chen N, Wu R, Lam Y, Chan W, Chan D Bone Rep. 2023; 19:101698.

PMID: 37485234 PMC: 10359737. DOI: 10.1016/j.bonr.2023.101698.


Suppressing Chondrocyte Hypertrophy to Build Better Cartilage.

Shigley C, Trivedi J, Meghani O, Owens B, Jayasuriya C Bioengineering (Basel). 2023; 10(6).

PMID: 37370672 PMC: 10295138. DOI: 10.3390/bioengineering10060741.


Lineage-specific differences and regulatory networks governing human chondrocyte development.

Richard D, Pregizer S, Venkatasubramanian D, Raftery R, Muthuirulan P, Liu Z Elife. 2023; 12.

PMID: 36920035 PMC: 10069868. DOI: 10.7554/eLife.79925.


Genes in the Development and Maintenance of the Vertebrate Skeleton: Implications for Human Pathologies.

Levi G, Narboux-Neme N, Cohen-Solal M Cells. 2022; 11(20).

PMID: 36291143 PMC: 9600099. DOI: 10.3390/cells11203277.


Anti-Dlx5 Retards the Progression of Osteoarthritis through Inhibiting Chondrocyte Hypertrophy and Apoptosis.

Lu Y, Zhang C, Jiang S, Yuan F Evid Based Complement Alternat Med. 2022; 2022:5019920.

PMID: 35280506 PMC: 8906946. DOI: 10.1155/2022/5019920.